ElevateBio and Affini-T partner on KRAS therapies; Casma raises $46M to drug the cell’s garbage disposal system

Affini-T is the latest to sign on with ElevateBio, former Alexion head David Hallal’s one-stop-shop for cell and gene therapy manufacturing. Affini-T will use ElevateBio’s lentiviral vector system to engineer cell therapies targeted at KRAS.

Affini-T and ElevateBio declined to disclose any financial details of the deal. Affini-T launched out...

Click to view original post